p53 Regulation of G2 checkpoint is retinoblastoma protein dependent

被引:147
作者
Flatt, PM
Tang, LJ
Scatena, CD
Szak, ST
Pietenpol, JA
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
D O I
10.1128/MCB.20.12.4210-4223.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, we investigated the role of p53 in G(2) checkpoint function by determining the mechanism by which p53 prevents premature exit from G(2) arrest after genotoxic stress. Using three cell model systems, each isogenic, we showed that either ectopic or endogenous p53 sustained a G(2) arrest activated by ionizing radiation or adriamycin, The mechanism was p21 and retinoblastoma protein (pRB) dependent and involved an initial inhibition of cyclin B1-Cdc2 activity and a secondary decrease in cyclin B1 and Cdc2 levels. Abrogation of p21 or pRB function in cells containing wild-type p53 blocked the down-regulation of cyclin B1 and Cdc2 expression and led to an accelerated exit from G(2) after genotoxic stress. Thus, similar to what occurs in p21 and p53 deficiency, pRB loss can uncouple S phase and mitosis after genotoxic stress in tumor cells. These results indicate that similar molecular mechanisms are required for p53 regulation of G(1) and G(2) checkpoints.
引用
收藏
页码:4210 / 4223
页数:14
相关论文
共 61 条
  • [1] The p53 network
    Agarwal, ML
    Taylor, WR
    Chernov, MV
    Chernova, OB
    Stark, GR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 1 - 4
  • [2] P53 CONTROLS BOTH THE G(2)/M AND THE G(1) CELL-CYCLE CHECKPOINTS AND MEDIATES REVERSIBLE GROWTH ARREST IN HUMAN FIBROBLASTS
    AGARWAL, ML
    AGARWAL, A
    TAYLOR, WR
    STARK, GR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) : 8493 - 8497
  • [3] Azzam EI, 1997, CELL GROWTH DIFFER, V8, P1161
  • [4] RESEARCHERS GAIN FOOTHOLDS IN THE CELL-CYCLE
    BLUME, E
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (20) : 1504 - 1505
  • [5] Disruption of p53 in human cancer cells alters the responses to therapeutic agents
    Bunz, F
    Hwang, PM
    Torrance, C
    Waldman, T
    Zhang, YG
    Dillehay, L
    Williams, J
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) : 263 - 269
  • [6] Requirement for p53 and p21 to sustain G2 arrest after DNA damage
    Bunz, F
    Dutriaux, A
    Lengauer, C
    Waldman, T
    Zhou, S
    Brown, JP
    Sedivy, JM
    Kinzler, KW
    Vogelstein, B
    [J]. SCIENCE, 1998, 282 (5393) : 1497 - 1501
  • [7] 14-3-3σ is required to prevent mitotic catastrophe after DNA damage
    Chan, TA
    Hermeking, H
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1999, 401 (6753) : 616 - 620
  • [8] CELL-CYCLE REGULATION OF THE HUMAN CDC2 GENE
    DALTON, S
    [J]. EMBO JOURNAL, 1992, 11 (05) : 1797 - 1804
  • [9] de Toledo SM, 1998, CELL GROWTH DIFFER, V9, P887
  • [10] DEGREGORI J, 1995, MOL CELL BIOL, V15, P5846